Philips implements first commercial use of web-based PACS solution in Europe

PhilipsRadiology department goes filmless at Rotterdam's St Franciscus Hospital
Rotterdam – Philips Medical Systems (Philips), a division of Royal Philips Electronics (NYSE:PHG, AEX:PHI), yesterday officially began the delivery of its iSite Picture Archiving and Communication System (PACS) service to the St Franciscus Hospital in Rotterdam, the Netherlands. The service lets doctors read studies – including clinical images – from anywhere in the hospital, increasing productivity and the quality of patient care.

The operations of the system will be monitored and managed from the Philips iSite remote control center in San Francisco, North America. The combination of proactive remote monitoring and support allows Philips to identify and correct many potential issues before they impact the user’s work in the hospital. The service includes routine work like daily back-ups and routine systems maintenance, which can be performed by Philips without intervention from hospital employees. The locally-based hospital system administrators' tasks are focused around quality control and support of the clinical users.

Philips' iSite is the fastest growing enterprise PACS in Europe. It has been developed by Stentor, a company Philips acquired in 2005. iSite makes filmless image distribution in the hospital possible without the prohibitive up-front capital expenditures associated with traditional PACS. iSite PACS integrates into a health care institution's existing infrastructure and is today used by hundreds of leading hospitals and imaging centers.

The Rotterdam St Franciscus Hospital is pleased with the system because it improves workflow and patient care. Head of Radiology Ruud van der Marel explains: "Philips iSite was designed by clinicians who believe that improved patient care is the most important goal when developing a product. Clinical time should be spent on diagnosis and therapy, not trying to decipher multiple tabs and buttons. All our images are immediately available with the click of the mouse. And because we believe that PACS is life critical, Philips provides a 99.99% uptime guarantee."

Philips' European Healthcare Informatics director Ton van den Hoven commented: "Often frustrated by PACS implementations that take too long to implement and prove too expensive, European hospitals have taken notice of the success of iSite in the US. In Rotterdam we were able to implement iSite in a few months, a timescale which is unheard of for a PACS installation. We can do that because it is a flexible and open system that easily adapts to the existing infrastructure. iSite Enterprise provides clinicians and referring physicians access to instant diagnostic-quality images anytime, anyplace throughout their healthcare environment."

For further information please contact:
Gert van Santen
Corporate Communications
Royal Philips Electronics Amsterdam
Tel: +31 40 27 82682

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is one of the world's biggest electronics companies and Europe's largest, with sales of EUR 30.4 billion in 2005. With activities in the three interlocking domains of healthcare, lifestyle and technology and 161,500 employees in more than 60 countries, it has market leadership positions in medical diagnostic imaging and patient monitoring, color television sets, electric shavers, lighting and silicon system solutions. News from Philips is located at www.philips.com/newscentre.

Most Popular Now

Artificial Intelligence: Unexpected Resu…

Artificial intelligence (AI) is on the rise. Until now, AI applications generally have "black box" character: How AI arrives at its results remains hidden. Prof. Dr. Jürgen Bajorath, a cheminformatics...

Printed Robots with Bones, Ligaments, an…

3D printing is advancing rapidly, and the range of materials that can be used has expanded considerably. While the technology was previously limited to fast-curing plastics, it has now been...

AI identifies Non-Smokers at High Risk f…

Using a routine chest X-ray image, an artificial intelligence (AI) tool can identify non-smokers who are at high risk for lung cancer, according to a study being presented next week...

Orchestrating the New World of AI in Hea…

Orion Health's UK and Ireland Customer Conference 2023 focused on the future potential and immediate, practical application of AI to healthcare - and gave delegates a first look at the...

Study Reveals Bias in AI Tools when Diag…

Machine learning algorithms designed to diagnose a common infection that affects women showed a diagnostic bias among ethnic groups, University of Florida researchers found. While artificial intelligence (AI) tools offer...

Researchers Take New AI Approach to Anal…

Researchers at Karolinska Institutet and SciLifeLab in Sweden have combined artificial intelligence (AI) techniques used in satellite imaging and community ecology to interpret large amounts of data from tumour tissue...

Medical AI Tool from UF, NVIDIA gets Hum…

A new artificial intelligence (AI) computer program created by researchers at the University of Florida and NVIDIA can generate doctors' notes so well that two physicians couldn't tell the difference...

Commission Opens Calls to Invest €42 Mil…

Today, the European Commission opened a new set of calls for proposals under the 2023-2024 Work Programmes of the Digital Europe Programme with a focus on advanced digital skills. The calls...

Bayer Championing Advancements in Radiol…

Bayer continues to advance its comprehensive Radiology portfolio with progress in the development pipeline of its investigational contrast agent as well as new innovations in the area of Artificial Intelligence...

MEDICA and COMPAMED: Medical Technology …

13 - 16 November 2023, Düsseldorf, Germany. After four days of business, MEDICA and COMPAMED in Düsseldorf delivered impressive confirmation that they are excellent platforms for the worldwide medical technology business...

AI Predicts Developmental Paths in Prema…

Researchers at UMC Utrecht have developed an AI model to predict long-term outcome in extremely premature babies early in life. The model can identify which infants might face intellectual disability...

AI Paves Way for New Medicines

A team of researchers from LMU, ETH Zurich, and Roche Pharma Research and Early Development (pRED) Basel has used artificial intelligence (AI) to develop an innovative method that predicts the...